It just became too cheap.
At just over $200m MC, you received approx $100m in cash and CTD shares, with the CTD share price at a low given market conditions.
If you look back at FY19 numbers, that's mid to low single digit EV/EBITDA multiples on the remaining business (post recent sale to CTD)... Now that the Chinese can travel again and cruising kicked off in Aus (~October onwards), FY19 numbers are definitely achievable.
HLO is still cheap, without a doubt. Cruising has kicked off, many agents have left the space, and HLO have a very talented MD. Look at his track record post acquisition/merger, and he's improved the business on many counts. Granted, HLO was a mess beforehand, but he cleaned things up and truly exceeded synergy targets.
This has more to run, and shareholders should receive CTD shares through in-specie distributions (once escrow is over), as well as increased dividends.
- Forums
- ASX - By Stock
- HLO valuation thread
HLO
helloworld travel limited
Add to My Watchlist
3.00%
!
$1.38

It just became too cheap.At just over $200m MC, you received...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.38 |
Change
0.040(3.00%) |
Mkt cap ! $224.5M |
Open | High | Low | Value | Volume |
$1.34 | $1.38 | $1.33 | $2.044M | 1.521M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21208 | $1.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.39 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21208 | 1.360 |
1 | 14814 | 1.350 |
1 | 15000 | 1.345 |
2 | 20973 | 1.335 |
7 | 41386 | 1.330 |
Price($) | Vol. | No. |
---|---|---|
1.390 | 5000 | 1 |
1.395 | 3860 | 2 |
1.400 | 11112 | 1 |
1.410 | 10000 | 1 |
1.415 | 20000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
HLO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online